Market Research Report
Pharma ADMET Testing Market 2017-2027: In Vitro, In Vivo, In Silico, Leading Developed Markets, Leading Emerging Markets, Leading Companies
|Published by||Visiongain Ltd||Product code||341090|
|Published||Content info||149 Pages
Delivery time: 1-2 business days
|Pharma ADMET Testing Market 2017-2027: In Vitro, In Vivo, In Silico, Leading Developed Markets, Leading Emerging Markets, Leading Companies|
|Published: June 28, 2017||Content info: 149 Pages||
The pharma ADMET testing market is estimated at $7.43bn in 2016 and is expected to grow at a CAGR of 12.32% in the first half of the forecast period. The market is expected to grow at a CAGR of 10.50% in the second half of the forecast period. In 2016, the largest sector of the market was in vitro testing, which accounted for 44.3% of the ADMET testing market.
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 149-page report you will receive 100 charts- all unavailable elsewhere.
The 149-page report provides clear detailed insight into the pharma ADMET testing market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Our study includes SWOT and STEP analysis of this industry and market.
A company profile gives you the following information where available:
Visiongain's study is intended for anyone requiring commercial analyses for the pharma ADMET Testing market. You find data, trends and predictions.